E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/14/2006 in the Prospect News Biotech Daily.

ICON reiterated at buy by Jefferies

Jefferies & Co., Inc. analyst David Windley reiterated ICON plc at buy and raised the price target to $80 following a lab tour at the company. Management described the ICON's growing customer base, backlog and momentum, according to the analyst. Shares of the Dublin, Ireland-based contract research organization were up $2.68, or 4.05%, at $68.90, on volume of 98,075 shares versus the three-month running average of 86,495 shares. (Nasdaq: ICLR)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.